gsk glp 1 agonist Science's 2023 Breakthrough: GLP-1R Agonists Glucagon-like peptide-1 receptor agonists in
Description
After removing 2,716 duplicate records, 3,825 studies underwent title and abstract screening
By dampening reward-driven behaviors, GLP-1 agonists could potentially reduce cravings and compulsive substance use
patients receiving ADMs saw noticeable spikes in the rate of discontinuation due to medication availability in January 2023 (5.3%) and June 2024 (4.8%), while patients receiving AOMs experienced higher rates of discontinuation due to medication availability throughout 2023 and into early 2024
Regul Pept (1996) 63:1722
